These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5041510)

  • 21. Treatment of cocaine abuse with monoamine oxidase inhibitors.
    Brewer C
    Br J Psychiatry; 1993 Dec; 163():815-6. PubMed ID: 8306127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Awareness and experience of general practitioners of selected drug interactions.
    Petrie JC; Howie JG; Durno D
    Br Med J; 1974 May; 2(5913):262-4. PubMed ID: 4827073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Interactions with monoamine oxidase inhibitors.
    McGilchrist JM
    Br Med J; 1975 Sep; 3(5983):591-2. PubMed ID: 1174832
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment.
    Levy AB; Bucher P; Votolato N
    Can J Psychiatry; 1985 Oct; 30(6):434-6. PubMed ID: 4063940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B; Osse RJ; Emmer B; van Kooten F
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
    Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychoses induced by chronic administration of barbiturates in combination with phenmetrazine].
    Vinarová E; Vinar O
    Cesk Psychiatr; 1971 Oct; 67(5):284-91. PubMed ID: 5119297
    [No Abstract]   [Full Text] [Related]  

  • 29. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.
    Dawson JK; Earnshaw SM; Graham CS
    J Accid Emerg Med; 1995 Mar; 12(1):49-51. PubMed ID: 7640830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between barbiturates, alcohol and some psychotropic drugs.
    Milner G
    Med J Aust; 1970 Jun; 1(24):1204-7. PubMed ID: 5451395
    [No Abstract]   [Full Text] [Related]  

  • 31. Phenelzine-induced sexual dysfunction treated with sildenafil.
    Gupta S; Masand P; Ashton AK; Berry SL
    J Sex Marital Ther; 1999; 25(2):131-5. PubMed ID: 10327382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of MAOI antidepressants.
    Ravaris CL; Robinson DS; Nies A; Ives JO; Bartlett D
    Am Fam Physician; 1978 Jul; 18(1):105-11. PubMed ID: 665471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use and abuse of the psychotropic drugs.
    Enelow AJ
    J Okla State Med Assoc; 1973 Aug; 66(8):355-9. PubMed ID: 4584731
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic psychosis induced by high-dosage chlorpromazine therapy.
    Beszterczey A; Pecknold JC
    Can Med Assoc J; 1971 May; 104(10):884 passim. PubMed ID: 5574054
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K; Grohmann R; Hippius H; Rüther E
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract]   [Full Text] [Related]  

  • 38. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I; Spigset O
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mysterious MAOI hypertensive episodes.
    Linet LS
    J Clin Psychiatry; 1986 Nov; 47(11):563-5. PubMed ID: 3095312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphadenopathy associated with monoamine oxidase inhibitors.
    Kallab AM; Marley EM; Frei-Lahr D
    Am J Hematol; 1999 Feb; 60(2):167. PubMed ID: 9929114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.